# Xin Xie

> Xin Xie is the cofounder and CEO of Xellar Biosystems, based in Cambridge, Massachusetts. An electrical engineering graduate of Shanghai Jiao Tong University and Northeastern University, he researched micro actuators and origami-based microfluidic devices before working at TransMedics and cofounding Xellar at the end of 2021. His career connects physical engineering, research commercialization, laboratory automation and artificial intelligence.

- **Role:** Cofounder and CEO at Xellar Biosystems
- **Organizations:** Xellar Biosystems, TransMedics, Northeastern University, Harvard University, ApreX Biotech
- **Education:** Bachelor of Engineering, Electrical Engineering, Shanghai Jiao Tong University, PhD, Electrical Engineering, Northeastern University, Boston University
- **Known for:** Earned a PhD in electrical engineering from Northeastern University in 2017., First author of research on pivot-hinged micro motion amplifiers and origami-based microfluidic fabrication., Cofounded Xellar Biosystems and serves as its CEO.

## Career timeline

- **2006-2010** — Studied electrical engineering at Shanghai Jiao Tong University.
- **2015** — Presented actuator research at PowerMEMS in Boston as a Northeastern doctoral student.
- **2016** — Coauthored a pivot-hinged micro motion amplifier paper with Carol Livermore.
- **2017** — Completed an electrical engineering PhD at Northeastern, advised by Carol Livermore.
- **2018** — Identified by Northeastern as a postdoctoral researcher and member of the ApreX Biotech research team.
- **Before founding Xellar** — Worked at TransMedics in biomedical and systems engineering.
- **2021-2022** — Cofounded Xellar at the end of 2021; professional listings date his CEO role from January 2022.
- **2026** — Led Xellar as it announced $50 million in Series A and A+ financing and launched DeepInsight.

## Achievements

- Earned a PhD in electrical engineering from Northeastern University in 2017.
- First author of research on pivot-hinged micro motion amplifiers and origami-based microfluidic fabrication.
- Cofounded Xellar Biosystems and serves as its CEO.
- Led Xellar when it announced $50 million in Series A and A+ financing on June 29, 2026.

## Latest updates

- **2026-08** — Presented the DeepInsight AI platform at an August 27 Shanghai launch event accompanying Xellar Intelligence branding and announced partnerships with Tencent Cloud, MoleculeMind and BioMap.
- **2026-06** — Xellar announced the closing of $50 million in Series A and A+ financing on June 29.

## Links

- Website: https://xellarbio.com/
- LinkedIn: https://www.linkedin.com/in/xxstevenee

---

Profile page: https://yespress.io/xin-xie
Published by YesPress — https://yespress.io
Last updated: 2026-10-26